| June 9, 2016 |
Jens Holstein, CFO |
Sale of 9,997 MorphoSys AG shares; the shares sold derive from the Long-Term-Incentive (LTI-) Program 2012 of MorphoSys; from overall 12,997 shares out of this program, Mr. Holstein holds 3,000 shares. |
June 7, 2016
XETRA, EUR 47.017
EUR 470,028.949 |
| May 17, 2016 |
Dr. Marlies Sproll, CSO |
Sale of 3,100 MorphoSys AG shares; the shares sold derive from the Long-Term-Incentive (LTI-) Program 2012 of MorphoSys; from overall 12,997 shares out of this program, Dr. Sproll holds 6,760 shares. |
May 13, 2016
XETRA, EUR 45.1284
EUR 139,898.04 |
| May 17, 2016 |
Dr. Marlies Sproll, CSO |
Sale of 3,137 MorphoSys AG shares; the shares sold derive from the Long-Term-Incentive (LTI-) Program 2012 of MorphoSys; from overall 12,997 shares out of this program, Dr. Sproll holds 6,760 shares. |
May 12, 2016
XETRA, EUR 43.8891
EUR 137,680.11 |
| December 17, 2015 |
Dr. Simon Moroney, CEO |
Purchase: 18,800 convertible bonds were converted into MorphoSys AG shares. Dr. Moroney is holding the shares received. |
December 16, 2015
off-exchange, EUR 16.79
EUR 315,252.00 |
| December 17, 2015 |
Dr. Marlies Sproll, CSO |
Sale: 9,500 convertible bonds were converted into MorphoSys AG shares and subsequently sold. |
December 16, 2015
XETRA, EUR 56.1934
EUR 533,837.30 |
| December 17, 2015 |
Dr. Marlies Sproll, CSO |
Purchase: 14,000 convertible bonds were converted into MorphoSys AG shares. Dr. Sproll is holding the shares received. |
December 15, 2015
off-exchange, EUR 16.79
EUR 235,060.00 |
| December 17, 2015 |
Dr. Marlies Sproll, CSO |
Sale: 9,500 convertible bonds were converted into MorphoSys AG shares and subsequently sold. |
December 15, 2015
XETRA, EUR 56.0253
EUR 532,240.35 |
| June 8, 2015 |
Dr. Marlies Sproll, CSO |
Sale of 2,667 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. |
June 4, 2015
XETRA, EUR 65.6343
EUR 175,046.68 |
| June 8, 2015 |
Dr. Marlies Sproll, CSO |
Sale of 2,667 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. |
June 3, 2015
XETRA, EUR 65.8605
EUR 175,649.95 |
| June 8, 2015 |
Dr. Marlies Sproll, CSO |
Sale of 2,666 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. |
June 2, 2015
XETRA, EUR 65.6746
EUR 175,088.48 |
| June 8, 2015 |
Jens Holstein, CFO |
Sale of 3,381 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. |
June 4, 2015
XETRA, EUR 65.6343
EUR 221,909.57 |
| June 8, 2015 |
Jens Holstein, CFO |
Sale of 5,381 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. |
June 3, 2015
XETRA, EUR 65.8605
EUR 354,395.35 |
| June 8, 2015 |
Jens Holstein, CFO |
Sale of 5,370 MorphoSys AG shares; the shares were granted within MorphoSys's long term incentive (LTI) program 2011 after a four-year waiting period. The shares were subsequently sold. |
June 2, 2015
XETRA, EUR 65.6746
EUR 352,672.60 |
| May 13, 2015 |
Dr. Frank Morich, Deputy Chairman of the Supervisory Board |
Purchase of 1,000 MorphoSys AG shares |
May 12, 2015
Frankfurt, EUR 63.51
EUR 63,510.00 |
| Apr 2, 2015 |
Dr. Gerald Möller,
Chairman of the Supervisory Board |
Purchase of 2,000 MorphoSys AG shares |
March 27, 2015
Frankfurt, EUR 56.70
EUR 113,400.00 |
| Apr 2, 2015 |
Karin Eastham, Member of the Supervisory Board |
Purchase of 1,000 MorphoSys AG shares |
March 27, 2015
OTC, USD 61.8129
USD 61,812.90 |